REQUEST A DEMO
Total
USD $0.00
Search more companies

The Ibn Sina Pharmaceutical Industry Plc (Bangladesh)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: The Ibn Sina Pharmaceutical Industry Plc Profile Updated: September 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The Company involves in the production of pharmaceutical drugs and natural medicines and selling them in both local and international market.
The Company was founded on 22 December, 1983 in a campus of about 15 acres of land, about 56 km away from Dhaka city. The industry was established by the Board of Trustee as a Private Limited Company. Then, it was converted into a Public Limited Company in 1989.
The commercial production was started on May 1986
The Company was quoted on Dhaka Stock Exchange in 1989 and on Chittagong Stock Exchange on 24 December 1996.
The Company has Changed its Name from The IBN SINA Pharmaceutical Industry Ltd to The IBN SINA Pharmaceutical Industry PLC. On February 26, 2023,

Headquarters
Tanin Center, Plot-3, Asad Gate, Mirpur Road, Mohammadpur
Dhaka; Dhaka; Postal Code: 1207

Contact Details: Purchase the The Ibn Sina Pharmaceutical Industry Plc report to view the information.

Website: http://www.ibnsinapharma.com

Basic Information
Total Employees:
Purchase the The Ibn Sina Pharmaceutical Industry Plc report to view the information.
Outstanding Shares:
Purchase the The Ibn Sina Pharmaceutical Industry Plc report to view the information.
Registered Capital:
Purchase the The Ibn Sina Pharmaceutical Industry Plc report to view the information.
Financial Auditors:
Purchase the The Ibn Sina Pharmaceutical Industry Plc report to view the information.
Incorporation Date:
1983
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
44.31%
Purchase this report to view the information.
31.52%
Purchase this report to view the information.
24.17%
Subsidiaries
The Ibn Sina Api Industry Ltd (Pakistan)
The Ibn Sina Natural Medicine Ltd (Pakistan)
The Ibn Sina Polymer Industry Ltd (Pakistan)
Company Performance
Financial values in the chart are available after The Ibn Sina Pharmaceutical Industry Plc report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BDT. Absolute financial data is included in the purchased report.
Net sales revenue
26.21%
Total operating revenue
26.21%
Operating profit (EBIT)
17.82%
EBITDA
14.85%
Net Profit (Loss) for the Period
13.22%
Total assets
28.12%
Total equity
17.22%
Operating Profit Margin (ROS)
-0.64%
Net Profit Margin
-0.74%
Return on Equity (ROE)
-0.41%
Debt to Equity Ratio
7.03%
Quick Ratio
-0.13%
Cash Ratio
-0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?